638 related articles for article (PubMed ID: 11773546)
1. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.
Mitchell WG; Davalos-Gonzalez Y; Brumm VL; Aller SK; Burger E; Turkel SB; Borchert MS; Hollar S; Padilla S
Pediatrics; 2002 Jan; 109(1):86-98. PubMed ID: 11773546
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia.
Mitchell WG; Brumm VL; Azen CG; Patterson KE; Aller SK; Rodriguez J
Pediatrics; 2005 Oct; 116(4):901-7. PubMed ID: 16199699
[TBL] [Abstract][Full Text] [Related]
3. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
Rudnick E; Khakoo Y; Antunes NL; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Matthay KK
Med Pediatr Oncol; 2001 Jun; 36(6):612-22. PubMed ID: 11344492
[TBL] [Abstract][Full Text] [Related]
4. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome.
Tate ED; Allison TJ; Pranzatelli MR; Verhulst SJ
J Pediatr Oncol Nurs; 2005; 22(1):8-19. PubMed ID: 15574722
[TBL] [Abstract][Full Text] [Related]
5. Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies.
Hayward K; Jeremy RJ; Jenkins S; Barkovich AJ; Gultekin SH; Kramer J; Crittenden M; Matthay KK
J Pediatr; 2001 Oct; 139(4):552-9. PubMed ID: 11598603
[TBL] [Abstract][Full Text] [Related]
6. Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up.
Catsman-Berrevoets CE; Aarsen FK; van Hemsbergen ML; van Noesel MM; Hakvoort-Cammel FG; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2009 Dec; 53(6):1048-53. PubMed ID: 19672966
[TBL] [Abstract][Full Text] [Related]
7. [Opsoclonus myoclonus ataxia syndrome in Israel].
Blumkin L; Lerman-Sagie T
Harefuah; 2010 Jan; 149(1):24-8, 63. PubMed ID: 20422836
[TBL] [Abstract][Full Text] [Related]
8. [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
Plantaz D; Michon J; Valteau-Couanet D; Coze C; Chastagner P; Bergeron C; Nelken B; Martelli H; Peyroulet MC; Carpentier AF; Armari-Alla C; Pagnier A; Rubie H
Arch Pediatr; 2000 Jun; 7(6):621-8. PubMed ID: 10911528
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma.
Koh PS; Raffensperger JG; Berry S; Larsen MB; Johnstone HS; Chou P; Luck SR; Hammer M; Cohn SL
J Pediatr; 1994 Nov; 125(5 Pt 1):712-6. PubMed ID: 7525913
[TBL] [Abstract][Full Text] [Related]
10. Delayed, recurrent opsoclonus-myoclonus syndrome responding to plasmapheresis.
Armstrong MB; Robertson PL; Castle VP
Pediatr Neurol; 2005 Nov; 33(5):365-7. PubMed ID: 16243225
[TBL] [Abstract][Full Text] [Related]
11. Late neurologic and cognitive sequelae of inflicted traumatic brain injury in infancy.
Barlow KM; Thomson E; Johnson D; Minns RA
Pediatrics; 2005 Aug; 116(2):e174-85. PubMed ID: 16061571
[TBL] [Abstract][Full Text] [Related]
12. Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses.
Ertle F; Behnisch W; Al Mulla NA; Bessisso M; Rating D; Mechtersheimer G; Hero B; Kulozik AE
Pediatr Blood Cancer; 2008 Mar; 50(3):683-7. PubMed ID: 17226843
[TBL] [Abstract][Full Text] [Related]
13. In the long run...longitudinal studies of psychopathology in children. Committee on Child Psychology. Group for the Advancement of Psychiatry. Report no.143.
Rep Group Adv Psychiatry; 1999; (143):1-183. PubMed ID: 10230287
[TBL] [Abstract][Full Text] [Related]
14. High dose pulsatile dexamethasone therapy in children with opsoclonus-myoclonus syndrome.
Rostásy K; Wilken B; Baumann M; Müller-Deile K; Bieber I; Gärtner J; Möller P; Angelini P; Hero B
Neuropediatrics; 2006 Oct; 37(5):291-5. PubMed ID: 17236108
[TBL] [Abstract][Full Text] [Related]
15. Neurologic and developmental outcome in treated congenital toxoplasmosis.
Roizen N; Swisher CN; Stein MA; Hopkins J; Boyer KM; Holfels E; Mets MB; Stein L; Patel D; Meier P
Pediatrics; 1995 Jan; 95(1):11-20. PubMed ID: 7770286
[TBL] [Abstract][Full Text] [Related]
16. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.
Fattal-Valevski A; Kesler A; Sela BA; Nitzan-Kaluski D; Rotstein M; Mesterman R; Toledano-Alhadef H; Stolovitch C; Hoffmann C; Globus O; Eshel G
Pediatrics; 2005 Feb; 115(2):e233-8. PubMed ID: 15687431
[TBL] [Abstract][Full Text] [Related]
17. Clinical practice guideline: Otitis media with effusion.
Rosenfeld RM; Culpepper L; Doyle KJ; Grundfast KM; Hoberman A; Kenna MA; Lieberthal AS; Mahoney M; Wahl RA; Woods CR; Yawn B; ; ;
Otolaryngol Head Neck Surg; 2004 May; 130(5 Suppl):S95-118. PubMed ID: 15138413
[TBL] [Abstract][Full Text] [Related]
18. [A boy with acute cerebellar ataxia without opsoclonus caused by neuroblastoma].
Blokker RS; Smit LM; van den Bos C; Overberg PC; Caron HN; Kaspers GJ
Ned Tijdschr Geneeskd; 2006 Apr; 150(14):799-803. PubMed ID: 16649400
[TBL] [Abstract][Full Text] [Related]
19. Myoclonic encephalopathy of infants or "dancing eyes syndrome". Report of 7 cases with long-term follow-up and review of the literature (cases with and without neuroblastoma).
Boltshauser E; Deonna T; Hirt HR
Helv Paediatr Acta; 1979 May; 34(2):119-33. PubMed ID: 222713
[TBL] [Abstract][Full Text] [Related]
20. [Opsoclonus myoclonus syndrome: how long are we going to go on researching?].
Ramos S; Temudo T
Rev Neurol; 2002 Aug 16-31; 35(4):322-5. PubMed ID: 12235560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
